Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Pharmacist-Physician Collaboration Improves Pediatric Hypertension Outcomes
01/05/2024
Pharmacist-physician collaborative drug therapy management improved outcomes compared with traditional care in pediatric patients with hypertension, according to a single-clinic study published in The Journal of Pediatric Pharmacology and...
Pharmacist-physician collaborative drug therapy management improved outcomes compared with traditional care in pediatric patients with hypertension, according to a single-clinic study published in The Journal of Pediatric Pharmacology and...
Pharmacist-physician...
01/05/2024
Pharmacy Learning Network

Advertisement

News
PCA Rx Partners With Cost Plus Drugs to Bring Transparency to Drug Pricing
01/05/2024
Pharmacy benefit manager PCA Rx recently announced a collaboration with Mark Cuban Cost Plus Drug Company to offer employers and members clarity and openness in drug pricing in an industry known for hidden costs.
Pharmacy benefit manager PCA Rx recently announced a collaboration with Mark Cuban Cost Plus Drug Company to offer employers and members clarity and openness in drug pricing in an industry known for hidden costs.
Pharmacy benefit manager PCA Rx...
01/05/2024
Pharmacy Learning Network
News
Antibiotic Pulled
01/03/2024
Cardinal Healthcare pulled three units of amoxicillin for oral suspension because it was exposed to temperatures outside its labeled storage conditions. The recall was included in the January 3, 2024, US Food and Drug Administration (FDA)...
Cardinal Healthcare pulled three units of amoxicillin for oral suspension because it was exposed to temperatures outside its labeled storage conditions. The recall was included in the January 3, 2024, US Food and Drug Administration (FDA)...
Cardinal Healthcare pulled three...
01/03/2024
Pharmacy Learning Network
News
Uric Acid Reducer Recalled
01/03/2024
Allopurinol tablets were recalled by Cardinal Healthcare due to exposure to temperatures outside labeled storage conditions, according to the January 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Allopurinol tablets were recalled by Cardinal Healthcare due to exposure to temperatures outside labeled storage conditions, according to the January 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Allopurinol tablets were...
01/03/2024
Pharmacy Learning Network

Advertisement

News
COPD Drug Recalled
01/03/2024
Cardinal Healthcare voluntarily initiated the recall January 26, 2022. On December 26, 2023, the FDA designated the recall Class II. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if...
Cardinal Healthcare voluntarily initiated the recall January 26, 2022. On December 26, 2023, the FDA designated the recall Class II. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if...
Cardinal Healthcare voluntarily...
01/03/2024
Pharmacy Learning Network
News
These Programs Put Unused Prescription Drugs in the Hands of Patients in Need
12/27/2023
Many states in the US allow drug donation programs to redispense unexpired, unopened medications to uninsured patients so they can access their treatments at low or no cost.
Many states in the US allow drug donation programs to redispense unexpired, unopened medications to uninsured patients so they can access their treatments at low or no cost.
Many states in the US allow drug...
12/27/2023
Pharmacy Learning Network
News
Chelating Agent Recalled
12/21/2023
Lupin Pharmaceuticals Inc. is recalling a single lot of penicillamine tablets. The December 20, 2023, US Food and Drug Administration (FDA) Enforcement Report cited failed dissolution specifications as the reason for the recall.
Lupin Pharmaceuticals Inc. is recalling a single lot of penicillamine tablets. The December 20, 2023, US Food and Drug Administration (FDA) Enforcement Report cited failed dissolution specifications as the reason for the recall.
Lupin Pharmaceuticals Inc. is...
12/21/2023
Pharmacy Learning Network

Advertisement

News
A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?
12/21/2023
How insurers will respond to the availability of tests isn’t clear, partly because the arrival of new biosimilar drugs — essentially generic versions — are making TNFis cheaper for insurance plans. While Humira still dominates, AbbVie has...
How insurers will respond to the availability of tests isn’t clear, partly because the arrival of new biosimilar drugs — essentially generic versions — are making TNFis cheaper for insurance plans. While Humira still dominates, AbbVie has...
How insurers will respond to the...
12/21/2023
Pharmacy Learning Network
News
Chemotherapy Tablets Recalled
12/20/2023
Three lots of Votrient distributed throughout the United States by Novartis Pharmaceuticals Corporation are being recalled because samples of the drug failed to meet dissolution specifications, according to the December 20, 2023, US Food and...
Three lots of Votrient distributed throughout the United States by Novartis Pharmaceuticals Corporation are being recalled because samples of the drug failed to meet dissolution specifications, according to the December 20, 2023, US Food and...
Three lots of Votrient...
12/20/2023
Pharmacy Learning Network
News
Thyroid Medication Recalled
12/20/2023
More than 96,000 bottles of liothyronine sodium tablets were recalled by Sun Pharmaceutical Industries Inc. for failing to meet impurity/degradation specifications, according to the December 20, 2023, US Food and Drug Administration (FDA)...
More than 96,000 bottles of liothyronine sodium tablets were recalled by Sun Pharmaceutical Industries Inc. for failing to meet impurity/degradation specifications, according to the December 20, 2023, US Food and Drug Administration (FDA)...
More than 96,000 bottles of...
12/20/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use